Demand for Cancer Biopsy in Japan

Future Market Insights

Key Insight

The demand for cancer biopsy in Japan is projected to grow from USD 1.7 billion in 2025 to USD 6.4 billion by 2035, at a CAGR of 13.9%. Tissue Biopsies will dominate with a 48.0% market share, while kits and consumables will lead the product type segment with a 42.0% share.

November 28, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Cancer Biopsy in Japan

https://www.futuremarketinsights.com/reports/japan-cancer-biopsy-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

BD Japan
Dickinson
Fujifilm Healthcare
Hoya Corporation (Pentax Medical)
Sony Group
Sysmex Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Cancer Biopsy in Japan

Key Players

Similar Industry Reports